Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

PHARMA GUIDANCE ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2015 N/A 2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021e N/A 2022e N/A Bankruptcy risk for industry   0.9% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   0.0% 9.8% 4.4% 11.7% 6.6% 21.0% 19.7% 19.7%   Credit score (0-100)   0 28 49 22 38 5 5 5   Credit rating   N/A BB BBB BB BBB B B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2015 N/A 2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021e N/A 2022e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   0.0 -11.4 17.5 -20.6 19.8 -39.6 0.0 0.0   EBITDA   0.0 -11.4 17.5 -20.6 19.8 -39.6 0.0 0.0   EBIT   0.0 -11.4 17.5 -20.6 19.8 -39.6 0.0 0.0   Pre-tax profit (PTP)   0.0 -22.7 246.3 -302.5 70.4 13.9 0.0 0.0   Net earnings   0.0 -122.5 245.7 -302.5 70.4 13.9 0.0 0.0   Pre-tax profit without non-rec. items   0.0 -22.7 246 -302 70.4 13.9 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2015 N/A 2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021e N/A 2022e N/A Tangible assets total   0.0 14.0 14.0 14.0 14.0 14.0 0.0 0.0   Shareholders equity total   0.0 219 465 162 233 246 121 121   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   0.0 270 506 204 273 286 121 121   Net Debt   0.0 -250 -487 -187 -259 -268 -121 -121     See the entire balance sheet 1000.0 Volume  2015 N/A 2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021e N/A 2022e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   0.0 -11.4 17.5 -20.6 19.8 -39.6 0.0 0.0   Gross profit growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employees   0 1 1 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% -100.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   0 270 506 204 273 286 121 121   Balance sheet change%   0.0% 0.0% 87.6% -59.6% 33.5% 4.9% -57.6% 0.0%   Added value   0.0 -11.4 17.5 -20.6 19.8 -39.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 14 0 0 0 0 -14 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   0.0 -1.0 1.0 -1.0 1.0 -1.0 0.0 0.0   1000.0 Profitability  2015 N/A 2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021e N/A 2022e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   0.0% 100.0% 100.0% 100.0% 100.0% 100.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   0.0% -3.5% 63.5% -5.8% 31.2% 5.6% 0.0% 0.0%   ROI %   0.0% -4.4% 72.1% -6.6% 37.7% 6.5% 0.0% 0.0%   ROE %   0.0% -55.9% 71.9% -96.5% 35.7% 5.8% 0.0% 0.0%   1000.0 Solidity  2015 N/A 2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021e N/A 2022e N/A Equity ratio %   0.0% 81.2% 91.9% 79.4% 85.2% 86.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   0.0% 2,197.1% -2,781.3% 905.7% -1,308.0% 676.5% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 56,372,000.0% 812,200.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2015 N/A 2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021e N/A 2022e N/A Quick Ratio   0.0 5.0 11.9 4.5 6.4 6.9 0.0 0.0   Current Ratio   0.0 5.0 11.9 4.5 6.4 6.9 0.0 0.0   Cash and cash equivalent   0.0 249.8 487.1 186.7 258.9 267.9 0.0 0.0   1000.0 Capital use efficiency  2015 N/A 2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021e N/A 2022e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   0.0 2.9 19.8 -1.3 14.4 196.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2015 N/A 2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021e N/A 2022e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 -11 18 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 -11 18 0 0 0 0 0   EBIT / employee   0 -11 18 0 0 0 0 0   Net earnings / employee   0 -122 246 0 0 0 0 0